Press releases & news
Clinical expert: “IndiTreat could become an important puzzle-piece within cancer treatment” (BioStock)
The article is in Swedish. Read it here
2cureX gathered decision makers at New Year’s Reception
Yesterday, January 31, 2019, 2cureX AB (“2cureX”) arranged 2cureX New Year’s Reception, an event where the company together with its...
2cureX will pre-launch IndiTreat® in 2019 (BioStock)
BioStock article: 2cureX will pre-launch IndiTreat® in 2019 The article is in Swedish. Read it here
2cureX Quarterly Newsletter
1st Edition November 24th 2018 Read 2cureX Newsletter #1.
2cureX expands clinical trials IndiTreat in 3rd cancer area (BioStock)
BioStock article about 2cureX´s expansion clinical trials IndiTreat in 3rd cancer area. The article is in Swedish. Read it here.
2cureX presented at “Stora Aktiedagen”, 26th November in Stockholm
CEO Ole Thastrup and CBO Maarten van der Linden presented 2cureX at “Stora Aktiedagen” in Stockholm.
Laboratory: 2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark|
Phone: +45 2211 5399|